Research is being conducted on precision medicine for colon cancer, with studies exploring its potential to transform care. The role of various factors, including birth characteristics and liquid biopsy, are being examined in relation to colorectal cancer risk and treatment. Additionally, advancements in precision oncology and new therapies are also being investigated, although it is unclear how these developments specifically relate to colon cancer treatment versus other types of cancer, such as gastric cancer.